Transarterial embolization for uterine fibroids:: Clinical success rate and results of magnetic resonance imaging

被引:12
作者
Kröncke, TJ
Gauruder-Burmester, A
Scheurig, C
Gronewold, M
Klüner, C
Fischer, T
Klessen, C
Rudolph, J
Siara, K
Zimmermann, E
Hamm, B
机构
[1] Humboldt Univ, Inst Radiol, Charite, D-10117 Berlin, Germany
[2] Humboldt Univ, Charite Univ Med Berlin, Klin Frauenheilkunde & Geburtshilfe, D-10117 Berlin, Germany
[3] Univ Hamburg, Klinikum Eppendorf, Klin & Poliklin Frauenheilkunde & Geburtshilfe, Hamburg, Germany
来源
ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN | 2005年 / 177卷 / 01期
关键词
interventional radiology; vascular interventions; embolization; uterus; leiomyomas;
D O I
10.1055/s-2004-813739
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To analyze the clinical success rate and the findings of magnetic resonance imaging (MRI) after uterine artery embolio zation of symptomatic leiomyomas (fibroids) of the uterus. Materials and Methods: This is a prospective single-center case study of 80 consecutively treated patients. followed for 3-6 months (group 1), 7 - 12 months, (group 11), and 13 - 25 months (group 111). MRI was used to deter-mine the uterine volume and size of the dominant leiomyoma. Symproms and causes requiring repeat interventions were analyzed. Results: Sigificant (p < 0.01) volume reduction of the uterus (median: 34.95% confidence interval [CI]: 30.41 -41.76X) and dominant leiomyoma (median: 52.07%, CI: 47.71 -61.57Z) was found. The decrease in uterine volume (I-III: 22.68%, 33.56%, 47.93%) and dominant leiomyoma volume (I-III: 41.86%, 62.16%. 73.96%) progressed with the follow-up rime. Bleeding resolved significantly (p < 0.0001) in all three follow-up groups (groups I-III: 92.86%, 95.23%, 96.67%). Furthermore, urinary frequency (groups I-III: 70%, 75%, 82.35%) and sensation of pelvic pressure (groups I-III: 42.86%, 60%, 93.75%) improved, which was statistically significant in group III (p < 0.01). The number of leiomyomas correlated (p < 0.05) with improvement of the bleeding and the pelvic pressure. Repeat therapy was necessary for complications in four patients (5%) and for therapeutic failure in three patients (3.8%) Permanent amenorrhea was observed in four patients (5%) of age 45 years or older. Conclusion: Uterine artery embolization of uterine leiomyomas has a high clinical success rate with an acceptable incidence of complications and repeat interventions.
引用
收藏
页码:89 / 98
页数:10
相关论文
共 30 条
[1]   Uterine artery embolization treatment of uterine fibroids: Effect on ovarian function in younger women [J].
Ahmad, A ;
Qadan, L ;
Hassan, N ;
Najarian, K .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2002, 13 (10) :1017-1020
[2]  
American College of Obstetricians and Gynecologists, 2004, OBSTET GYNECOL, V103, P403
[3]  
AYDENIZ B, 2003, FRAUENARZT, V44, P1274
[4]   Transcatheter uterine artery embolisation to treat large uterine fibroids [J].
Bradley, EA ;
Reidy, JF ;
Forman, RG ;
Jarosz, J ;
Braude, PR .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1998, 105 (02) :235-240
[5]   The impact of uterine fibroid embolization on resumption of menses and ovarian function [J].
Chrisman, HB ;
Saker, MB ;
Ryu, RK ;
Nemcek, AA ;
Gerbie, MV ;
Milad, MP ;
Smith, SJ ;
Sewall, LE ;
Omary, RA ;
Vogelzang, RL .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2000, 11 (06) :699-703
[6]   Pathologic features of uteri and leiomyomas following uterine artery embolization for leiomyomas [J].
Colgan, TJ ;
Pron, G ;
Mocarski, EJM ;
Bennett, JD ;
Asch, MR ;
Common, A .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2003, 27 (02) :167-177
[7]  
David M, 2003, FRAUENARZT, V44, P1164
[8]  
FRIESE K, 2002, DTSCH ARZTEBLATT, V9, P1826
[9]   Infection after embolisation of uterine leiomyomata requiring hysterectomy [J].
Gaetje, R ;
Zangos, S ;
Vogl, T ;
Kaufmann, M .
GEBURTSHILFE UND FRAUENHEILKUNDE, 2003, 63 (02) :156-159
[10]   Pregnancy after uterine artery embolization [J].
Goldberg, J ;
Pereira, L ;
Berghella, V .
OBSTETRICS AND GYNECOLOGY, 2002, 100 (05) :869-872